Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine

The combination of cisplatin and gemcitabine is still one of the most frequently used first-line chemotherapy scheme in patients with advanced non-small cell lung cancer (NSCLC), in which tyrosine kinase inhibitors (TKIs) cannot be administered. Unfortunately, more than half of the patients have no...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pathol Oncol Res
Autori principali: Mlak, Radosław, Krawczyk, Paweł, Homa-Mlak, Iwona, Powrózek, Tomasz, Ciesielka, Marzanna, Kozioł, Piotr, Milanowski, Janusz, Małecka-Massalska, Teresa
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Netherlands 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6614130/
https://ncbi.nlm.nih.gov/pubmed/30066234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-018-0459-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi